Abstract 49P
Background
To date, miR-155 is known as an oncogenic miRNA with a well-documented role in breast cancer. Cancer stemness plays an important role in various aspects of carcinogenesis. The aim of this study is to investigate the effect of miR-155 on breast cancer proliferation by upregulating cancer stem cells.
Methods
In vivo-tumor growth and metastasis were measured across polyomavirus middle T antigen (PyVmT) transgenic mice and PyVmT miR-155 knockout mice. Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to determine the protein and mRNA levels, respectively. The cancer stemness was assessed by sphere formation as well as the expression of the related markers. The miR-155 target genes were predicted and analyzed by western blot and luciferase assay.
Results
Upregulation of miR-155 in breast cancer tissues of mice identified poor prognosis and cancer metastasis. Upregulation of miR-155 was also found in breast cancer stem cells. Ectopic expression of miR-155 promotes the stemness of breast cancer cells. Conversely, depletion of miR-155 attenuates the stemness of these cells. miR-155 directly binds to CYLD and Sharp-1 to influence breast cancer stemness.
Conclusions
MicroRNA-155 promotes breast cancer progression by upregulating breast cancer stemness.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
10P - An adapted CGP-based model to interpret POLE mutations in endometrial cancer
Presenter: Rita Trozzi
Session: Cocktail & Poster Display session
Resources:
Abstract
11P - Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations
Presenter: Rija Zaidi
Session: Cocktail & Poster Display session
Resources:
Abstract
12P - Swiss-PO: Molecular modelling for precision oncology
Presenter: Fanny Krebs
Session: Cocktail & Poster Display session
Resources:
Abstract
13P - A novel algorithm for predicting variant detectability in oncogenomic analysis
Presenter: Alper Akkuş
Session: Cocktail & Poster Display session
Resources:
Abstract
14P - expHRD: An algorithm for the transcriptome-based estimation of homologous recombination deficiency score
Presenter: Jin-Ku Lee
Session: Cocktail & Poster Display session
Resources:
Abstract
15P - ClinBioNGS: An integrated clinical bioinformatics pipeline for the analysis of somatic NGS cancer panels
Presenter: Xavier Sole
Session: Cocktail & Poster Display session
Resources:
Abstract
16P - Investigation of c-MYC role in DNA-PK-mediated activation of STING pathway in SCLC
Presenter: Caterina de Rosa
Session: Cocktail & Poster Display session
Resources:
Abstract
17P - NRF2 activation promotes HER2-targeted tolerance and resistance in oesophageal adenocarcinoma through metabolic reprogramming to glutathione
Presenter: Wei Zhang
Session: Cocktail & Poster Display session
Resources:
Abstract
18P - AURKB inhibition radiosensitises NSCLC by altering mitotic fate
Presenter: Kathryn Egerton
Session: Cocktail & Poster Display session
Resources:
Abstract
19P - Stratified control study on neuroendocrine differentiation and potential clinical markers in patients with limited-stage small-cell lung cancer
Presenter: Li Liu
Session: Cocktail & Poster Display session
Resources:
Abstract